Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Treatment burden should be included in clinical practice guidelines.

Dobler CC, Harb N, Maguire CA, Armour CL, Coleman C, Murad MH.

BMJ. 2018 Oct 12;363:k4065. doi: 10.1136/bmj.k4065. No abstract available.

PMID:
30314981
2.

A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.

Fathima M, Saini B, Foster JM, Armour CL.

Res Social Adm Pharm. 2019 Jun;15(6):662-672. doi: 10.1016/j.sapharm.2018.08.007. Epub 2018 Aug 14.

PMID:
30131254
3.

Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.

Dobler CC, Bosnic-Anticevich S, Armour CL.

ERJ Open Res. 2018 Mar 23;4(1). pii: 00146-2017. doi: 10.1183/23120541.00146-2017. eCollection 2018 Jan.

4.

Patient Preferences for Managing Insomnia: A Discrete Choice Experiment.

Cheung JMY, Bartlett DJ, Armour CL, Saini B, Laba TL.

Patient. 2018 Oct;11(5):503-514. doi: 10.1007/s40271-018-0303-y.

PMID:
29502237
5.

Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective.

Fathima M, Saini B, Foster JM, Armour CL.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 18;12:2753-2761. doi: 10.2147/COPD.S145073. eCollection 2017.

6.

Patient Perceptions of Treatment Delivery Platforms for Cognitive Behavioral Therapy for Insomnia.

Cheung JMY, Bartlett DJ, Armour CL, Laba TL, Saini B.

Behav Sleep Med. 2019 Jan-Feb;17(1):81-97. doi: 10.1080/15402002.2017.1293539. Epub 2017 Mar 21.

PMID:
28323439
7.

Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.

Bajorek BV, LeMay KS, Magin PJ, Roberts C, Krass I, Armour CL.

Int J Pharm Pract. 2017 Aug;25(4):263-273. doi: 10.1111/ijpp.12301. Epub 2016 Sep 16.

PMID:
27633151
8.

Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges.

Bajorek B, Lemay KS, Magin P, Roberts C, Krass I, Armour CL.

Pharm Pract (Granada). 2016 Apr-Jun;14(2):723. doi: 10.18549/PharmPract.2016.02.723. Epub 2016 Jun 15.

9.

To Drug or Not to Drug: A Qualitative Study of Patients' Decision-Making Processes for Managing Insomnia.

Cheung JMY, Bartlett DJ, Armour CL, Laba TL, Saini B.

Behav Sleep Med. 2018 Jan-Feb;16(1):1-26. doi: 10.1080/15402002.2016.1163702. Epub 2016 May 18.

PMID:
27191585
10.

Preparing pharmacists to deliver a targeted service in hypertension management: evaluation of an interprofessional training program.

Bajorek BV, Lemay KS, Magin PJ, Roberts C, Krass I, Armour CL.

BMC Med Educ. 2015 Sep 28;15:157. doi: 10.1186/s12909-015-0434-y.

11.

A snapshot of pharmacist attitudes and behaviors surrounding the management of pediatric asthma.

Elaro A, Shah S, Armour CL, Bosnic-Anticevich S.

J Asthma. 2015;52(9):957-68. doi: 10.3109/02770903.2015.1020387. Epub 2015 Aug 18.

PMID:
26291141
12.

Treating Insomnia: A Review of Patient Perceptions Toward Treatment.

Cheung JM, Bartlett DJ, Armour CL, Saini B.

Behav Sleep Med. 2016;14(3):235-66. doi: 10.1080/15402002.2014.981818. Epub 2015 Aug 4.

PMID:
26240937
13.

People with insomnia: experiences with sedative hypnotics and risk perception.

Cheung JM, Bartlett DJ, Armour CL, Ellis JG, Saini B.

Health Expect. 2016 Aug;19(4):935-47. doi: 10.1111/hex.12388. Epub 2015 Aug 3.

14.

An exploration of clinical interventions provided by pharmacists within a complex asthma service.

Lemay KS, Saini B, Bosnic-Anticevich S, Smith L, Stewart K, Emmerton L, Burton DL, Krass I, Armour CL.

Pharm Pract (Granada). 2015 Jan-Mar;13(1):529. Epub 2015 Mar 15.

15.

Effectiveness of computerized clinical decision support systems for asthma and chronic obstructive pulmonary disease in primary care: a systematic review.

Fathima M, Peiris D, Naik-Panvelkar P, Saini B, Armour CL.

BMC Pulm Med. 2014 Dec 2;14:189. doi: 10.1186/1471-2466-14-189. Review.

16.

A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma.

Naik-Panvelkar P, Saini B, LeMay KS, Emmerton LM, Stewart K, Burton DL, Bosnic-Anticevich SZ, Krass I, Smith LD, Armour CL.

Int J Pharm Pract. 2015 Jun;23(3):182-91. doi: 10.1111/ijpp.12134. Epub 2014 Jul 4.

PMID:
24995681
17.

Patient asthma networks: understanding who is important and why.

Cheong LH, Armour CL, Bosnic-Anticevich SZ.

Health Expect. 2015 Dec;18(6):2595-605. doi: 10.1111/hex.12231. Epub 2014 Jun 30.

18.

Human Lung Mast Cell Products Regulate Airway Smooth Muscle CXCL10 Levels.

Alkhouri H, Cha V, Tong K, Moir LM, Armour CL, Hughes JM.

J Allergy (Cairo). 2014;2014:875105. doi: 10.1155/2014/875105. Epub 2014 Feb 6.

19.

Using scenarios to test the appropriateness of pharmacist prescribing in asthma management.

Hanna T, Bajorek B, Lemay K, Armour CL.

Pharm Pract (Granada). 2014 Jan;12(1):390. Epub 2014 Mar 24.

20.

CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro.

Alkhouri H, Moir LM, Armour CL, Hughes JM.

Clin Exp Allergy. 2014 Mar;44(3):381-92. doi: 10.1111/cea.12224.

PMID:
24588865
21.

Performance of a brief asthma control screening tool in community pharmacy: a cross-sectional and prospective longitudinal analysis.

LeMay KS, Armour CL, Reddel HK.

Prim Care Respir J. 2014 Mar;23(1):79-84. doi: 10.4104/pcrj.2014.00011.

22.

Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.

Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, Yamamoto Y, Schmidt AM, Armour CL, Hughes JM, Phipps S, Sukkar MB.

J Allergy Clin Immunol. 2014 Aug;134(2):440-50. doi: 10.1016/j.jaci.2013.12.1035. Epub 2014 Feb 4.

PMID:
24506934
23.

The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review.

Fathima M, Naik-Panvelkar P, Saini B, Armour CL.

Pharm Pract (Granada). 2013 Oct;11(4):228-45. Epub 2013 Dec 20.

24.

Checklists for powder inhaler technique: a review and recommendations.

Basheti IA, Bosnic-Anticevich SZ, Armour CL, Reddel HK.

Respir Care. 2014 Jul;59(7):1140-54. doi: 10.4187/respcare.02342. Epub 2013 Oct 15. Review.

25.

Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1.

Che W, Parmentier J, Seidel P, Manetsch M, Ramsay EE, Alkhouri H, Ge Q, Armour CL, Ammit AJ.

Am J Respir Cell Mol Biol. 2014 Feb;50(2):358-68. doi: 10.1165/rcmb.2013-0208OC.

PMID:
24032470
26.

RAGE and TLRs: relatives, friends or neighbours?

Ibrahim ZA, Armour CL, Phipps S, Sukkar MB.

Mol Immunol. 2013 Dec;56(4):739-44. doi: 10.1016/j.molimm.2013.07.008. Epub 2013 Aug 14. Review.

PMID:
23954397
27.

Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.

Tan X, Alrashdan YA, Alkhouri H, Oliver BG, Armour CL, Hughes JM.

Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L790-802. doi: 10.1152/ajplung.00356.2012. Epub 2013 Apr 5.

28.

Insomnia patients' help-seeking experiences.

Cheung JM, Bartlett DJ, Armour CL, Glozier N, Saini B.

Behav Sleep Med. 2014 Mar 4;12(2):106-22. doi: 10.1080/15402002.2013.764529. Epub 2013 Mar 20.

PMID:
23514322
29.

The insomnia patient perspective, a narrative review.

Cheung JM, Bartlett DJ, Armour CL, Saini B.

Behav Sleep Med. 2013;11(5):369-89. doi: 10.1080/15402002.2012.694382. Epub 2013 Feb 12. Review.

PMID:
23402684
30.

Primary health care teams and the patient perspective: a social network analysis.

Cheong LH, Armour CL, Bosnic-Anticevich SZ.

Res Social Adm Pharm. 2013 Nov-Dec;9(6):741-57. doi: 10.1016/j.sapharm.2012.12.003. Epub 2013 Feb 8.

PMID:
23395532
31.

Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial.

Armour CL, Reddel HK, LeMay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, Song YJ, Alles MC, Burton DL, Emmerton L, Stewart K, Krass I.

J Asthma. 2013 Apr;50(3):302-9. doi: 10.3109/02770903.2012.754463. Epub 2012 Dec 28.

PMID:
23270495
32.

Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.

Seidel P, Alkhouri H, Lalor DJ, Burgess JK, Armour CL, Hughes JM.

Respir Res. 2012 Oct 4;13:90. doi: 10.1186/1465-9921-13-90.

33.

Multidisciplinary collaboration in primary care: through the eyes of patients.

Cheong LH, Armour CL, Bosnic-Anticevich SZ.

Aust J Prim Health. 2013;19(3):190-7. doi: 10.1071/PY12019.

PMID:
22951207
34.

Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia.

Emmerton LM, Smith L, LeMay KS, Krass I, Saini B, Bosnic-Anticevich SZ, Reddel HK, Burton DL, Stewart K, Armour CL.

BMC Health Serv Res. 2012 Jun 18;12:164. doi: 10.1186/1472-6963-12-164.

35.

RAGE: a new frontier in chronic airways disease.

Sukkar MB, Ullah MA, Gan WJ, Wark PA, Chung KF, Hughes JM, Armour CL, Phipps S.

Br J Pharmacol. 2012 Nov;167(6):1161-76. doi: 10.1111/j.1476-5381.2012.01984.x. Review.

36.

Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement.

Alrashdan YA, Alkhouri H, Chen E, Lalor DJ, Poniris M, Henness S, Brightling CE, Burgess JK, Armour CL, Ammit AJ, Hughes JM.

Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L1118-27. doi: 10.1152/ajplung.00232.2011. Epub 2012 Mar 2.

37.

Th1 cytokine-induced syndecan-4 shedding by airway smooth muscle cells is dependent on mitogen-activated protein kinases.

Tan X, Khalil N, Tesarik C, Vanapalli K, Yaputra V, Alkhouri H, Oliver BG, Armour CL, Hughes JM.

Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L700-10. doi: 10.1152/ajplung.00167.2011. Epub 2012 Jan 20.

38.

Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control.

Armour CL, Lemay K, Saini B, Reddel HK, Bosnic-Anticevich SZ, Smith LD, Burton D, Song YJ, Alles MC, Stewart K, Emmerton L, Krass I.

J Asthma. 2011 Nov;48(9):914-22. doi: 10.3109/02770903.2011.615431. Epub 2011 Sep 26.

PMID:
21942306
39.

User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia.

Basheti IA, Qunaibi E, Bosnic-Anticevich SZ, Armour CL, Khater S, Omar M, Reddel HK.

Respir Care. 2011 Dec;56(12):1916-23. doi: 10.4187/respcare.01205. Epub 2011 Jun 17.

40.

Human lung mast cells modulate the functions of airway smooth muscle cells in asthma.

Alkhouri H, Hollins F, Moir LM, Brightling CE, Armour CL, Hughes JM.

Allergy. 2011 Sep;66(9):1231-41. doi: 10.1111/j.1398-9995.2011.02616.x. Epub 2011 May 10.

PMID:
21557752
41.

Diabetes management in an Australian primary care population.

Krass I, Hebing R, Mitchell B, Hughes J, Peterson G, Song YJ, Stewart K, Armour CL.

J Clin Pharm Ther. 2011 Dec;36(6):664-72. doi: 10.1111/j.1365-2710.2010.01221.x. Epub 2011 Mar 1.

PMID:
21355875
42.

Long-term maintenance of pharmacists' inhaler technique demonstration skills.

Basheti IA, Armour CL, Reddel HK, Bosnic-Anticevich SZ.

Am J Pharm Educ. 2009 Apr 7;73(2):32.

43.

Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique.

Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK.

Patient Educ Couns. 2008 Jul;72(1):26-33. doi: 10.1016/j.pec.2008.01.014. Epub 2008 Mar 7.

PMID:
18314294
44.

The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J.

Diabet Med. 2007 Jun;24(6):677-83.

PMID:
17523968
45.

Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release.

Chhabra J, Li YZ, Alkhouri H, Blake AE, Ge Q, Armour CL, Hughes JM.

Eur Respir J. 2007 May;29(5):861-70.

46.

Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists.

Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ.

J Allergy Clin Immunol. 2007 Jun;119(6):1537-8. Epub 2007 Apr 16. No abstract available.

PMID:
17433831
47.

Interactive small-group asthma education in the community pharmacy setting: a pilot study.

Kritikos V, Armour CL, Bosnic-Anticevich SZ.

J Asthma. 2007 Jan-Feb;44(1):57-64.

PMID:
17365206
48.

Complementary and alternative medicine use in asthma: who is using what?

Slader CA, Reddel HK, Jenkins CR, Armour CL, Bosnic-Anticevich SZ.

Respirology. 2006 Jul;11(4):373-87. Review.

PMID:
16771907
49.

IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM.

Henness S, van Thoor E, Ge Q, Armour CL, Hughes JM, Ammit AJ.

Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1283-90.

50.

Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics.

Sutcliffe A, Kaur D, Page S, Woodman L, Armour CL, Baraket M, Bradding P, Hughes JM, Brightling CE.

Thorax. 2006 Aug;61(8):657-62. Epub 2006 Apr 6.

Supplemental Content

Loading ...
Support Center